Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Patient Preference and Adherence
|
October 25, 2014
Southern Saskatchewan Ticagrelor Registry experience
Payam Dehghani, Varun Chopra, Ali Bell, et al.
The Journal of Rheumatology
|
November 3, 2017
Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study
Leslie R Harrold, Heather J Litman, Sean E Connolly, et al.
Clinical Rheumatology
|
March 3, 2017
A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?
Leslie R Harrold, Heather J Litman, Sean E Connolly, et al.
Rheumatology International
|
May 26, 2020
Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry
Leslie R Harrold, Ying Shan, Sabrina Rebello, et al.
The Journal of Rheumatology
|
July 3, 2018
Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry
Evo Alemao, Heather J Litman, Sean E Connolly, et al.
Clinical Rheumatology
|
March 5, 2020
Prevalence of Sjögren's syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry
Leslie R Harrold, Ying Shan, Sabrina Rebello, et al.
Rheumatology and Therapy
|
December 23, 2021
Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA
Leslie R Harrold, Sean E Connolly, Keith Wittstock, et al.
Lupus Science & Medicine
|
December 8, 2017
Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial
Somnath Bandyopadhyay, Sean E Connolly, Omar Jabado, et al.
Palliative Medicine
|
September 13, 2013
Exploring public awareness and perceptions of palliative care: a qualitative study
Sonja McIlfatrick, Helen Noble, Noleen K McCorry, et al.
Healthcare Management Forum
|
July 12, 2011
A study of the effectiveness of performance-focused methodology for improved outcomes in Alberta public healthcare
Jason Werle, Loretta Dobbelsteyn, A Lynn Feasel, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Patient Preference and Adherence
|
October 25, 2014
Southern Saskatchewan Ticagrelor Registry experience
Payam Dehghani, Varun Chopra, Ali Bell, et al.
The Journal of Rheumatology
|
November 3, 2017
Effect of Anticitrullinated Protein Antibody Status on Response to Abatacept or Antitumor Necrosis Factor-α Therapy in Patients with Rheumatoid Arthritis: A US National Observational Study
Leslie R Harrold, Heather J Litman, Sean E Connolly, et al.
Clinical Rheumatology
|
March 3, 2017
A window of opportunity for abatacept in RA: is disease duration an independent predictor of low disease activity/remission in clinical practice?
Leslie R Harrold, Heather J Litman, Sean E Connolly, et al.
Rheumatology International
|
May 26, 2020
Disease activity and patient-reported outcomes in patients with rheumatoid arthritis and Sjögren's syndrome enrolled in a large observational US registry
Leslie R Harrold, Ying Shan, Sabrina Rebello, et al.
The Journal of Rheumatology
|
July 3, 2018
Do Poor Prognostic Factors in Rheumatoid Arthritis Affect Treatment Choices and Outcomes? Analysis of a US Rheumatoid Arthritis Registry
Evo Alemao, Heather J Litman, Sean E Connolly, et al.
Clinical Rheumatology
|
March 5, 2020
Prevalence of Sjögren's syndrome associated with rheumatoid arthritis in the USA: an observational study from the Corrona registry
Leslie R Harrold, Ying Shan, Sabrina Rebello, et al.
Rheumatology and Therapy
|
December 23, 2021
Baseline Anti-Citrullinated Protein Antibody Status and Response to Abatacept or Non-TNFi Biologic/Targeted-Synthetic DMARDs: US Observational Study of Patients with RA
Leslie R Harrold, Sean E Connolly, Keith Wittstock, et al.
Lupus Science & Medicine
|
December 8, 2017
Identification of biomarkers of response to abatacept in patients with SLE using deconvolution of whole blood transcriptomic data from a phase IIb clinical trial
Somnath Bandyopadhyay, Sean E Connolly, Omar Jabado, et al.
Palliative Medicine
|
September 13, 2013
Exploring public awareness and perceptions of palliative care: a qualitative study
Sonja McIlfatrick, Helen Noble, Noleen K McCorry, et al.
Healthcare Management Forum
|
July 12, 2011
A study of the effectiveness of performance-focused methodology for improved outcomes in Alberta public healthcare
Jason Werle, Loretta Dobbelsteyn, A Lynn Feasel, et al.
Page
of 4